News
- Author:
- Heidi Splete
Publish date: September 29, 2020
New guideline articulates a broad approach to treatment that needs to be tailored to individual patients.
News
- Author:
- Heidi Splete
Publish date: September 28, 2020
Many patients with irritable bowel syndrome don’t seek care. When they do, discuss time lines and triggers.
News
- Author:
- Heidi Splete
Publish date: September 28, 2020
Simulation study supports value of mifepristone and misoprostol for medical management of miscarriage.
News
- Author:
- Heidi Splete
Publish date: September 28, 2020
Potential etiology of acute pancreatitis in 2020 includes genetic factors, drugs, and comorbidities.
News
- Author:
- Heidi Splete
Publish date: September 25, 2020
Treat underlying factors such as obesity and diabetes to reduce risk of liver disease progression.
News
- Author:
- Heidi Splete
Publish date: September 24, 2020
Dr. Marcy B. Bolster addresses common patient concerns about bisphosphonate use.
News
- Author:
- Heidi Splete
Publish date: September 24, 2020
Demographics, obesity, and metabolic factors have emerged as main drivers of disease.
News
- Author:
- Heidi Splete
Publish date: September 24, 2020
Treat underlying factors such as obesity and diabetes to reduce risk of liver disease progression.
News
- Author:
- Heidi Splete
Publish date: September 23, 2020
Consider dose escalation and adding an immunomodulator to overcome the impact of antidrug antibodies in rheumatic disease patients.
News
- Author:
- Heidi Splete
Publish date: September 23, 2020
He highlights safety protocols and advises on recommended vaccines in rheumatology practice.
News
- Author:
- Heidi Splete
Publish date: September 18, 2020
Lupus drugs in late-stage development seek to address unmet needs, notably in lupus nephritis.
News
- Author:
- Heidi Splete
Publish date: September 11, 2020
Veterans Health Administration study shows decline in hepatocellular carcinoma after efforts to treat hepatitis C.
News
- Author:
- Heidi Splete
Publish date: September 8, 2020
Liver transplant did not impact hospitalization or need for intensive care in patients with COVID-19.
News
- Author:
- Heidi Splete
Publish date: September 3, 2020
A South Korean case series of 91 children with COVID-19 identified detectable viral RNA for approximately 2 weeks’ duration.
News
- Author:
- Heidi Splete
Publish date: September 3, 2020
Administration of evolocumab after PCI significantly improved LDL cholesterol levels within 4 weeks.
